Skip to content

A prospective, double-blind, randomized controlled trial for intravenous norepinephrine in the prevention and treatment of hypotension and cesarean section

A prospective, double-blind, randomized controlled trial for intravenous norepinephrine in the prevention and treatment of hypotension and cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020813
Enrollment
Unknown
Registered
2019-01-20
Start date
2019-01-21
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Interventions

5 groups (NE1, NE2, NE3, NE4, NE5):intravenous norepinephrine for treating hypotension

Sponsors

Lishui City Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy full-term, single-pregnancy and basal systolic pressure at 90 to 140 mm Hg, heart rate 60 to 100 beats/min, ASA I-II healthy maternal

Exclusion criteria

Exclusion criteria: Known fetal abnormalities, previous history of hypertension or gestational hypertension, cardiovascular or cerebrovascular disease, bradycardia or other types of arrhythmias, thrombocytopenia and dysfunction, coagulopathy Anyone with spinal anesthesia contraindications, phenylephrine or norepinephrine allergy, weight less than 50 kg or more than 100 kg, height less than 140 cm or greater than 180 cm, unable or refusal to sign informed consent, maternal age less than 18 years old.

Design outcomes

Primary

MeasureTime frame
blood pressure;

Countries

China

Contacts

Public ContactChen Min

Lishui City Maternal and Child Health Hospital

83183875@qq.com+86 1925728100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026